Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-19-002565
Filing Date
2019-04-09
Accepted
2019-04-09 12:22:26
Documents
52
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT plsi-10k_022817.htm 10-K 739690
2 CERTIFICATION PURSUANT TO SECTION 302 ex31-1.htm EX-31.1 14371
3 CERTIFICATION PURSUANT TO SECTION 302 ex31-2.htm EX-31.2 14123
4 CERTIFICATION PURSUANT TO SECTION 906 ex32-1.htm EX-32.1 6878
5 CERTIFICATION PURSUANT TO SECTION 906 ex32-2.htm EX-32.2 6698
12 GRAPHIC plsi110k-img_01.jpg GRAPHIC 697588
  Complete submission text file 0001387131-19-002565.txt   3934912

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plsi-20170228.xml EX-101.INS 303846
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plsi-20170228.xsd EX-101.SCH 39069
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plsi-20170228_cal.xml EX-101.CAL 36823
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plsi-20170228_def.xml EX-101.DEF 179276
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plsi-20170228_lab.xml EX-101.LAB 272717
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plsi-20170228_pre.xml EX-101.PRE 218562
Mailing Address 3000 LAWRENCE STREET DENVER CO 80205
Business Address 3000 LAWRENCE STREET DENVER CO 80205 1.720.699.7222
Phoenix Life Sciences International Limited. (Filer) CIK: 0001493212 (see all company filings)

EIN.: 460525378 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 333-167275 | Film No.: 19738989
SIC: 1311 Crude Petroleum & Natural Gas